A single enantiomer of a potent and selective inactivator of KIAA1363, a MAGE hydrolase an enzyme that is upregulated in aggressive cancers from various tissues (IC50 = 150 nM when tested as a racemic mixture in SK0V-3 cells) activity of the
A single enantiomer of a potent and selective inactivator of KIAA1363, a MAGE hydrolase an enzyme that is upregulated in aggressive cancers from various tissues (IC50 = 150 nM when tested as a racemic mixture in SK0V-3 cells) activity of the
A synthetic derivative of NDGA, a non-selective lipoxygenase inhibitor inhibits Sp1 transcription factor binding at the HIV long terminal repeat promoter and at the &alpha-ICP4 promoter, a gene essential for HSV replication, with IC<sub>50</sub>
A synthetic derivative of NDGA, a non-selective lipoxygenase inhibitor inhibits Sp1 transcription factor binding at the HIV long terminal repeat promoter and at the &alpha-ICP4 promoter, a gene essential for HSV replication, with IC<sub>50</sub>
An ester of a naturally occurring phenolic compound that demonstrates antihyperglycemic and antidiabetic activity as well as induces anti-inflammatory and antinociceptive effects.
An ester of a naturally occurring phenolic compound that demonstrates antihyperglycemic and antidiabetic activity as well as induces anti-inflammatory and antinociceptive effects.
A major urinary metabolite of PGD2 with a unique lower sidechain that readily undergoes reversible cyclization used as a biomarker to assess endogenous production of PGD2.
A major urinary metabolite of PGD2 with a unique lower sidechain that readily undergoes reversible cyclization used as a biomarker to assess endogenous production of PGD2.